Combination therapies represent a promising frontier in cancer treatment, addressing the critical need to enhance efficacy while minimizing resistance. By combining different therapeutic agents and ...
News-Medical.Net on MSN
Novel drug combination overcomes resistance in aggressive KRAS-mutated lung cancer
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
10don MSN
Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature ...
The growing resistance of bacteria to existing antimicrobial drugs is a major problem, making it essential to find new ways to treat bacterial infections. Sometimes, antibiotics alone are not ...
Analyst/Investor event showcases opportunities for KO-2806 (darlifarnib) in combination with PI3Kα inhibitors, KRAS inhibitors and antiangiogenic tyrosine kinase inhibitors (TKIs) Preliminary clinical ...
The field of oncology has witnessed remarkable progress in the treatment of solid tumors, yet the quest for optimal therapeutic outcomes remains a formidable challenge. Current clinical evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback